Mike Rulis
Tlf. (direkte): 4442 3573
Peter Haahr
Tlf. (direkte): 4442 1207
Tlf. (direkte): 4442 6175
Tlf. (direkte): 4443 7801
| Source: Novo Nordisk A/S
Bagsværd, Denmark, 31 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Read MoreBagsværd, Denmark, 24 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Read More